Pilot Study on the Effects of Neuromuscular Taping in Parkinson's Disease Patients

NCT03104049 | Completed DMC

• 1 other identifier: RP 07/15
• Study Type: interventional
• Target: 46
• Locations: 0 countries
• Sites: N/A

Brief Summary

Parkinson's disease (PD) is a degenerative disorder characterized by a symptom triad consisting on: tremor, rigidity and bradykinesia . To these symptoms it is often added postural alteration that can stand in two different attitudes, such as the camptocormia and the syndrome of Pisa . Progressing in its evolution, PD becomes increasingly disabling, making it difficult or even impossible daily activities such as washing or dressing.The abnormal posture, with alteration of the limbs, the neck and trunk, is a recurring feature in PD, with a frequency of about 30%. Between 2% and 12.3% are more severe abnormalities such as camptocormia, the syndrome of Pisa and the anterocollis. Several studies disease plug in Neuromuscular Taping technique (NMT) among rehabilitative tools in degenerative neurological syndromes. To the best of our knowledge, no applications were found in PD. Therefore, the current study was designed to evaluate quantitatively the effects of the NMT intervention on the trunk kinematics during standing position. More specifically, this study aims to compare the trunk kinematic variables of patients with PD who were treated with effective NMT versus those of the subjects who received only the pharmacological treatment.

Conditions

Parkinson Disease

Keywords

Parkinson's Disease; Neuromuscular taping; Trunk; Posture; Kinematic; rehabilitation

Outcome Measures

Primary Outcomes (1)

• Change in the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) rating scale total score between baseline evaluations and end of treatment

  Clinical measures were summarized as means and standard deviations for all the 46 patients.

  baseline and end of treatment (1 month)

Secondary Outcomes (4)

• Change in the Parkinson Disease Quality of life 8 total score between baseline evaluations and end of treatment

  baseline and end of treatment (1 month)

• Change in the Non Motor Symptoms scale total score between baseline evaluations and end of treatment

  baseline and end of treatment (1 month)

• Change in the EuroQol 5 total score between baseline evaluations and end of treatment

  baseline and end of treatment (1 month)

• Change in the Freezing of Gait total score between baseline evaluations and end of treatment

  baseline and end of treatment (1 month)

Study Arms (2)

the PD NMT Group

ACTIVE COMPARATOR

the NMT Group were treated with NMT

Device: Neuromuscular taping

The PD Group without NMT

NO INTERVENTION

The patients received only their usual pharmacological PD therapy

Interventions

Neuromuscular taping DEVICE

NMT applications: 1. rhomboid major muscle 2. muscles abdominals 3. spinal muscles 4. pectoralis major muscles 5. gastrocnemius muscle 6. upper trapezius muscle 7. anterior muscles of the neck

Also known as: NMT

the PD NMT Group

Eligibility Criteria

• Age: 60 Years - 80 Years
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Diagnosis of idiopathic PD by United Kingdom Brain Bank criteria
• No other significant neurological or orthopedic problems
• Age between 55 and 80 years
• MDS-UPDRS item 3.13 Posture between mild and moderate (definite flexion, scoliosis or leaning to one side)
• Patient able to walk independently or with minimal assistance for 10 meters

You may not qualify if:

• Disability to understand instructions required by the study (Informed Consent Test of Comprehension)
• primarily wheelchair bound
• Skin abrasions
• sensitive skin

Sponsors & Collaborators

• IRCCS San Raffaele Roma: lead
• Politecnico di Milano: collaborator

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian Disorders; Basal Ganglia Diseases; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Movement Disorders; Synucleinopathies; Neurodegenerative Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: INVESTIGATOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 27, 2017
• First Posted: April 7, 2017
• Study Start: November 20, 2015
• Primary Completion: December 18, 2016
• Study Completion: January 8, 2017
• Last Updated: April 10, 2024

Record last verified: 2024-04